Section Arrow
QNCX.NASDAQ
- Quince Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2026/04/15 14:13 EDT
Regular Hours
Last
 1.165
-0.085 (-6.80%)
Day High 
1.2199 
Prev. Close
1.25 
1-M High
3.8429 
Volume 
1.53M 
Bid
1.16
Ask
1.17
Day Low
1.12 
Open
1.17 
1-M Low
0.8 
Market Cap 
20.38M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.26 
20-SMA 1.1 
50-SMA 1.43 
52-W High 45.499 
52-W Low 0.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-16.80/-0.80
Enterprise Value
20.71M
Balance Sheet
Book Value Per Share
-2.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IMMPImmutep Limited0.612+0.2972+94.41%-- 
LIMNLiminatus Pharma Inc0.1889+0.0091+5.06%-- 
PPCBPropanc Biopharma Inc0.119+0.0215+22.05%0PE
ALLOAllogene Therapeutics2.045-0.235-10.31%-- 
CUECue Biopharma0.595+0.157+35.84%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.